BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Financings for Sept. 24, 2025

Sep. 24, 2025
Med-tech firms raising money in public or private financings, including: Amplifymd, Leo Cancer Care.
Read More

Other news to note for Sept. 24, 2025

Sep. 24, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Align Technology, Angelalign, Art-Islets, Austrianova, Avant Technologies, Cellcarta, Guardant Health, Lunit, NorthStar Medical, Quest Diagnostics, Terthera.
Read More

Regulatory actions for Sept. 24, 2025

Sep. 24, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Burning Rock, Fluid AI, Neuromod Devices, TSC Life.
Read More
Heartflow illustration

FDA clears Heartflow’s next-gen plaque analysis

Sep. 23, 2025
By Annette Boyle
Heartflow Inc. hasn’t skipped a beat in pumping out good news, with U.S. FDA 510(k) clearance for its next-gen plaque analysis algorithm and platform and Cigna coverage across all lines of coverage starting in October. The new algorithm improves plaque detection 21% compared to the first version of Heartflow’s algorithm.
Read More
Red arrow pointing downward on a stock market ticker

Funding crisis looms for European med tech

Sep. 23, 2025
By Shani Alexander
The lack of funding available for early-stage European med-tech and AI-based companies could soon see many go under as their current backers run out of capital, and new investors fail to materialize, Hubert Birner, managing partner at TVM Capital Life Science, told BioWorld.
Read More

Appointments and advancements for Sept. 23, 2025

Sep. 23, 2025
New hires and promotions in the med-tech industry, including: Bridge to Life, Healthtrackrx, Inventus Group.
Read More

Financings for Sept. 23, 2025

Sep. 23, 2025
Med-tech firms raising money in public or private financings, including: Caregility, Pictor.
Read More

In the clinic for Sept. 23, 2025

Sep. 23, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ultromics.
Read More

Other news to note for Sept. 23, 2025

Sep. 23, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bracken, Caristo Diagnostics, Compass Bioinformatics, Epic, Genomenon, Labconnect, Myriad, Quest, Sophia Genetics.
Read More

Regulatory actions for Sept. 23, 2025

Sep. 23, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bunkerhill Health, Cionic, Heartflow, Noul.
Read More
Previous 1 2 … 85 86 87 88 89 90 91 92 93 … 10237 10238 Next

Popular Stories

  • Today's news in brief

    BioWorld

    BioWorld briefs for March 18, 2026.

  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 17, 2026
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing